Machina Capital S.A.S. Exelixis, Inc. Transaction History

Machina Capital S.A.S.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$14.46 - $21.8 $252,110 - $380,083	-17,435 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$15.15 - $18.89 $102,095 - $127,299	6,739 Added 63.0%	17,435 $307,000
Q3 2019 Nov 12, 2019	SELL	$17.68 - $22.65 $54,348 - $69,626	-3,074 Reduced 22.32%	10,696 $189,000
Q2 2019 Jul 19, 2019	BUY	$18.93 - $24.75 $249,308 - $325,957	13,170 Added 2195.0%	13,770 $294,000
Q1 2019 May 14, 2019	BUY	$19.6 - $24.76 $11,760 - $14,856	600 New	600 $14,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.